194 related articles for article (PubMed ID: 23415926)
1. The management of overactive bladder refractory to medical therapy.
Robinson D; Giarenis I; Cardozo L
Maturitas; 2013 May; 75(1):101-4. PubMed ID: 23415926
[TBL] [Abstract][Full Text] [Related]
2. Overactive bladder: diagnosis and management.
Robinson D; Cardozo L
Maturitas; 2012 Feb; 71(2):188-93. PubMed ID: 22197347
[TBL] [Abstract][Full Text] [Related]
3. The medical management of refractory overactive bladder.
Robinson D; Giarenis I; Cardozo L
Maturitas; 2013 Apr; 74(4):386-90. PubMed ID: 23395402
[TBL] [Abstract][Full Text] [Related]
4. Management of refractory overactive bladder.
Giarenis I; Cardozo L
Minerva Ginecol; 2013 Feb; 65(1):41-52. PubMed ID: 23412019
[TBL] [Abstract][Full Text] [Related]
5. Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review.
Leong RK; De Wachter SG; van Kerrebroeck PE
Urol Int; 2010; 84(3):245-53. PubMed ID: 20389150
[TBL] [Abstract][Full Text] [Related]
6. Overactive bladder syndrome - management and treatment options.
Arnold J; McLeod N; Thani-Gasalam R; Rashid P
Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
[TBL] [Abstract][Full Text] [Related]
7. [Management of overactive bladder in women].
Peyronnet B; Rigole H; Damphousse M; Manunta A
Prog Urol; 2015 Nov; 25(14):877-83. PubMed ID: 26169251
[TBL] [Abstract][Full Text] [Related]
8. Management of overactive bladder syndrome.
Srikrishna S; Robinson D; Cardozo L; Vella M
Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
[TBL] [Abstract][Full Text] [Related]
9. New developments in the medical management of overactive bladder.
Robinson D; Giarenis I; Cardozo L
Maturitas; 2013 Nov; 76(3):225-9. PubMed ID: 23953245
[TBL] [Abstract][Full Text] [Related]
10. Managing overactive bladder.
Robinson D; Cardozo L
Climacteric; 2019 Jun; 22(3):250-256. PubMed ID: 31034265
[TBL] [Abstract][Full Text] [Related]
11. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
[TBL] [Abstract][Full Text] [Related]
12. [Update on the second line management of idiopathic overactive bladder].
Chartier-Kastler E; Castro-Diaz D; De Ridder D; Everaert K; Sievert KD; Spinelli M; van Kerrebroeck P
Prog Urol; 2009 Sep; 19(8):530-7. PubMed ID: 19699450
[TBL] [Abstract][Full Text] [Related]
13. An overview of treatment of overactive bladder syndrome in women.
Allahdin S; Oo N
J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
[TBL] [Abstract][Full Text] [Related]
14. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy.
Ridout AE; Yoong W
J Obstet Gynaecol; 2010 Feb; 30(2):111-4. PubMed ID: 20143965
[TBL] [Abstract][Full Text] [Related]
15. [Neuromodulation as a treatment for overactive bladder syndrome].
Smits MA; Marcelissen TA; van Kerrebroeck PE; de Wachter SG
Ned Tijdschr Geneeskd; 2012; 156(33):A4135. PubMed ID: 22894803
[TBL] [Abstract][Full Text] [Related]
16. Overactive Bladder.
White N; Iglesia CB
Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
[TBL] [Abstract][Full Text] [Related]
17. The challenge of overactive bladder therapy: alternative to antimuscarinic agents.
Lazzeri M; Spinelli M
Int Braz J Urol; 2006; 32(6):620-30. PubMed ID: 17201939
[TBL] [Abstract][Full Text] [Related]
18. The pharmacotherapy of overactive bladder.
Athanasopoulos A
Expert Opin Pharmacother; 2011 May; 12(7):1003-5. PubMed ID: 21291348
[TBL] [Abstract][Full Text] [Related]
19. The evaluation and management of refractory neurogenic overactive bladder.
Kurpad R; Kennelly MJ
Curr Urol Rep; 2014 Oct; 15(10):444. PubMed ID: 25118853
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of refractory overactive bladder.
Chen LC; Kuo HC
Low Urin Tract Symptoms; 2019 Sep; 11(4):177-181. PubMed ID: 30900373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
